Xcell Therapeutics Inc. (373110)
Market Closed
16 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
1,169. 00
+68
+6.1762%
₩
66.18B Market Cap
- P/E Ratio
- Div Yield
231,693 Volume
- Eps
₩ 1,101
Previous Close Want to track 373110 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xcell Therapeutics Inc. (373110) Statistics
Valuation metrics
Market Cap 66.18B
Enterprise value 19.86B
Trailing P/E (ttm) -1.45
Forward P/E -
PEG ratio -0.05
Price/Sales (ttm) 4.22
Price/Book (mrq) 4.25
Enterprise Value/Revenue 4.55
Enterprise Value/EBITDA -2.04
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 74.14K
Average volume (90 days) 209.8K
Price summary
52-Week low 951
52-Week high 2,580
Beta -
50-Day moving average 1,076.78
200-Day moving average 1,299.09
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.52%
Operating margin -2.54%
Operational effectiveness
Return on assets -0.87%
Return on equity -2.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 252.26
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -636.81
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 244.5
Total debt (mrq) -
Total Debt/Equity (mrq) 1.24
Current ratio (mrq) 1.28%
Book value per share (mrq) 250.17
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
